Open AccessImprovement in Progression-Free Survival in OCEANS Bevacizumab Arm: A Critical Point of View
Author(s) -
Federica Tomao,
Pierluigi Benedetti Panici
Publication year - 2012
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2012.44.6237
Subject(s) - medicine , bevacizumab , progression free survival , overall survival , oncology , chemotherapy
The authors analyze the critical points and the results of the paper OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer,published by Aghajanian C et al on 10 june 2012 in J Clin Onco
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom